Now in its 13th year, the Neurotech Investing & Partnering Conference is the premier business and investment conference for commercial neuroscience including pharmaceuticals, medical devices, diagnostics and neurosoftware. The conference features keynotes, investor panels, cutting edge company presentations, and panel discussions on a comprehensive selection of neurotech topics. Our goal is to provide a highly-interactive environment where cutting edge technologies, devices, drugs and therapies inspire new collaborations and secure financing to navigate the development path and ultimately reach patients.
Organized by the Neurotechnology Industry Organization and Cambridge Innovation Institute, the 13th annual conference will be held May 1-2, 2018 at the Renaissance Waterfront Hotel in Boston, MA.
The Neurotech Investing and Partnering Conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry.
This market-defining conference features keynotes on the state of the neurotech industry, cutting edge company presentations, leading translational research projects and panel discussions on a comprehensive selection of neurotech topics.